Regeneron Sues Sandoz Over Dozens Of Eye Drug Patents
By Ryan Harroff · August 28, 2024, 5:51 PM EDT
Regeneron Pharmaceuticals Inc. has taken competing biomedical company Sandoz Inc. to New Jersey federal court with an extensive complaint asserting 46 patents and claiming Sandoz infringed them all with a biosimilar...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login